Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.

Stevens K N, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz V S, Hopper J L, Dite G S, Apicella C, Southey M C, Schmidt M K, Broeks A, Van 't Veer L J, Tollenaar R A E M, Fasching P A, Beckmann M W, Hein A, Ekici A B, Johnson N, Peto J, dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin M J, Chanock S, Lissowska J, Hunter D J, Hoover R N, Thomas G D, Milne R L, Arias Pérez J I, González-Neira A, Benítez J, Burwinkel B, Meindl A, Schmutzler R K, Bartrar C R, Hamann U, Ko Y D, Brüning T, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Bogdanova N, Zalutsky J V, Rogov Y I, Antonenkova N, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma V-M, Hartikainen J, Chenevix-Trench G, Chen X, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon C M, Olson J, Giles G G, Baglietto L, McLean C A, Severi G, John E M, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight J A, Glendon G, Mulligan A M, Cox A, Brock I W, Elliott G, Cross S S, Pharoah P P, Dunning A M, Pooley K A, Humphreys M K, Wang J, Kang D, Yoo K-Y, Noh D-Y, Sangrajrang S, Gabrieau V, Brennan P, McKay J, Anton-Culver H, Ziogas A, Couch F J, Easton D F, , ,